Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma
Clinical trial NCT02490800 · COMPLETED
Trial details
- NCT number
- NCT02490800
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-20
- Primary completion
- 2022-09-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.